Shanghai Henlius Biotech, Inc. (HKG:2696)

Shanghai Henlius Biotech Revenue

Shanghai Henlius Biotech had revenue of 2.82B CNY in the half year ending June 30, 2025, with 12.76% growth. This brings the company's revenue in the last twelve months to 5.80B, up 2.79% year-over-year. In the year 2024, Shanghai Henlius Biotech had annual revenue of 5.72B with 6.11% growth.

• Revenue (ttm): 5.80B CNY
• Revenue Growth: +2.79%
• P/S Ratio: 5.98
• Revenue / Employee: 1.65M CNY
• Employees: 3,515
• Market Cap: 37.96B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	5.72B	329.54M	6.11%
Dec 31, 2023	5.39B	2.18B	67.82%
Dec 31, 2022	3.21B	1.53B	91.07%
Dec 31, 2021	1.68B	1.09B	186.34%
Dec 31, 2020	587.59M	496.66M	546.20%